东北制药：发布关联交易管理制度规范关联交易行为

Group 1 - The company has established a management system for related party transactions to standardize practices and protect the interests of the company and all shareholders [1] - The definition of related parties includes both legal entities and individuals, with clear delineation of related relationships and transaction scopes [1] - Different amounts of related party transactions require approval from the shareholders' meeting, board of directors, or general manager's office, with related directors and shareholders required to abstain from voting during the review [1] Group 2 - The company has set standards and content for the disclosure of related party transactions, such as transactions exceeding 300,000 yuan with individuals or 3 million yuan with legal entities, which account for more than 0.5% of net assets, must be disclosed in a timely manner [1] - The management system will take effect after being approved by the shareholders' meeting [1]